Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

In Vitro Diagnostics (IVD) News: Breaking In Vitro Diagnostics (IVD) News, Comments and Articles. - Page: 5

17:39 EDT 31st July 2014 | BioPortfolio

In Vitro Diagnostics (IVD) News - Page: 5Twitter RSS

Read the latest In Vitro Diagnostics (IVD) News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on In Vitro Diagnostics (IVD).

Search or Follow Our In Vitro Diagnostics (IVD) - Page: 5 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More In Vitro Diagnostics (IVD) - Page: 5 News.
You can also follow our In Vitro Diagnostics (IVD) - Page: 5 news stories on Twitter: @IVDiagnostics

Showing "invitro diagnostics vitro" News Articles 101 to 125 of 4,100+

Monday 28th July 2014

Sony DADC BioSciences and TSMC Receive AACC Industry Division Award

The 2014 American Association for Clinical Chemistry (AACC) today awarded Sony DADC BioSciences and Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) with its Best Abstract of Interest to the Industry Division Award. The winnin

GenMark Announces Positive Preliminary Second Quarter Results

- Second Quarter Revenue Expected to be $6.6 million, Up 71% Versus Prior Year Base Business - NexGen Sample to Answer System Branded ePlex™ - ePlex™ Instrument Development Completed and Manufacturing Transfer Initiated - Development of Overall ePlex™ System Projected by End of 2014 GenMark Diagnostics, Inc. (Nas...

Global Genomics Market 2014-2018

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Genomics Market 2014-2018https://www.reportbuyer.com/product/2255162/Global-Genomics-Market-2014-2018.htmlAbout GenomicsGenomics is the study of the genetic material or genomes of an organism. It is expected to be a strong basis for the discovery and development of diagnostic and therapeutic so...

Global Medical Biosensors Market 2014-2018

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Medical Biosensors Market 2014-2018https://www.reportbuyer.com/product/403457/Global-Medical-Biosensors-Market-2014-2018.htmlAboutMedical biosensors are used to analyze biological components with the help of physicochemical detectors. These biosensors monitor health status, disease betterment, and t...

AZ partners with Qiagen, Roche to develop plasma-based EGFR mutation tests

AstraZeneca plc (LSE:AZN; NYSE:AZN) announced a pair of deals on Monday to develop companion diagnostics that can detect non-small cell lung cancer (NSCLC) EGFR mutations directly from circulating tumor DNA in plasma samples. Under one deal, Qiagen N...

T2 amends IPO

Diagnostics company T2 Biosystems Inc. (Lexington, Mass.) amended its IPO on NASDAQ and now plans to sell 4 million shares at $15-$17. At the $16 midpoint, the company would raise $64 million and be valued at $288.4 million. Earlier this month, the c...

BioFire Awarded Purchasing Agreement with HealthTrust for FilmArray™ System

BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, today announced that it has recently signed a new purchasing agreement with HealthTrust to provide multi-target molecular diagnostics tests for its nearly 1,400 member facilities. Under the agreement, HealthTrust will provide its facilities with the opportunity to purchase BioF...

Alan D. Pierce, MD, FCAP, Joins Aurora Diagnostics as Chief Medical Officer

Aurora Diagnostics announced today that Alan Pierce, MD, is joining the Company as Chief Medical Officer effective September 1. “We welcome Dr. Pierce to the new role of Chief Medical Officer of Aurora Diagnostics,” said Daniel D. Crowley, Chief Executive Officer. “Aurora’s mission is to deliver high quality diagnostic results with excelle...

Oncolab, Inc. Exhibits Pioneering AMAS Cancer Test at AACC

CHICAGO, July 28, 2014 /PRNewswire-iReach/ -- June 28th, 2014 – Oncolab, the Boston-based laboratory which has developed the AMAS cancer test, is making its AACC debut (booth #4051) at this year's conference in Chicago.  To date, the test, which is a serum-based in vitro immunoassay, has been run for over 60,000 patients and is emerging as a significant tool in the fight against cancer...

AstraZeneca Gets Diagnostics Infusion With Roche, Qiagen Lung Cancer Deals

Pure pharma tap Roche’s diagnostics expertise to develop a companion blood-based test for candidate AZD9291 and enlists Qiagen to develop a non-invasive diagnostic for Iressa in non-small cell lung cancer.

Chlamydia, gonorrhea tests for BD Diagnostics’ molecular platform gain CE Mark

BD Diagnostics, part of US medical technology company Becton, Dickinson and Co (NYSE:BDX), said Monday that its BD ProbeTec Chlamydia trachomatis (CT) Qx Amplified DNA Assay and BD ProbeTec Neisseria...

Nalgene Encourages America to Drink Up!

New Bottle Design and Logo Benefits the Partnership for a Healthier America’s Drink Up Initiative Nalgene® has teamed with the Partnership for a Healthier America (PHA) in its Drink Up initiative, an effort that encourages Americans to drink more water, more often. Nalgene has designed an exclusive Drink Up reusable water bottle to help Americans dr...

Astute Medical, OCD partner to expand access to new acute kidney injury test

Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.

Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo

ABBOTT PARK, Ill., July 28, 2014 /PRNewswire/ -- Clinical laboratories around the world are helping to improve patient care while navigating an evolving health care environment. To help laboratories with increasing demands, Abbott (NYSE: ABT) is developing diagnostic solutions for today and tomorrow, which it will showcase during the American Association for Clinical Chemistry (AACC) Annual M...

Ortho-Clinical Diagnostics and Astute Medical to Develop Acute Kidney Injury Tests

Ortho-Clinical Diagnostics has entered into a strategic partnership with Astute Medical, under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK ® Test and ASTUTE140 ® Meter in certain markets in...

The Overtreatment Conundrum: Definiens Identifies Three Steps for Advancing Diagnostics to Reduce Unnecessary Cancer Treatment and Improve Patient Health

Definiens, the global leader in Tissue Phenomics™ for diagnostics development in oncology, today released tips for the development of diagnostics to help physicians make more informed decisions, reduce unnecessary treatment and improve overall patient health. As the global cost of cancer care continues to rise exponentially, tests based on data generated...

CN Bio Innovations Marks World Hepatitis Day by Signing Research Agreement with Imperial College London

Collaboration will develop and further validate CN Bio’s in vitro model of Hepatitis B liver infection CN Bio Innovations Ltd (CN Bio), an expert in developing leading edge human biomimetic platforms to test and develop therapeutics for serious diseases, announced today that it has signed a research agreement with Imperial College London to advance t...

Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients

Northridge dentist, Dr. Ariz, is currently offering new patients a $100 coupon to use toward dental treatments. Northridge, CA (PRWEB) July 28, 2014 Top Northridge dentist, Dr. Farshid Ariz, is now offering a $100 coupon for new patients. Finding a new dentist can be an intimidating experience. Many people struggle with dental anxiety or dental issues that have gone untreated and worry about how...

Financial Results, Election to Board, Upcoming Conference Call, and Recognitions - Research Reports on Thermo Fisher, Quest Diagnostics, LabCorp, PAREXEL International and Quintiles

NEW YORK, July 28, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Thermo Fisher Scientific Inc. (NYSE: TMO), Quest Diagnostics Inc (NYSE: DGX), Laboratory Corp...

HD Medical Launches Channel Advantage Program for Distributors, Partners and OEMs

Support Program Delivers Significant Channel Advantages for Unique Visual Stethoscope Amidst growing distributor, partner and OEM demand for its new visual stethoscope, ViScope®, HD Medical, Inc. launches its new “Channel Advantage™” program. The phi

CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China

Agreement Represents Second CANbridge Product, First Medical Device CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has entered into an exclusive partnership with EUSA Pharma, a Jazz Pharmaceuticals company (Nasdaq:JAZZ), to commercialize Caphosol® in China. Under the terms of...

Thermo Fisher Scientific Launches LC-MS-Based Class I Medical Devices

HPLC, mass spectrometer and software designed for clinical analyses Clinical laboratories now have access to a new high-performance liquid chromatograph, mass spectrometer and LC-MS software designed and manufactured as FDA Class I devices to be components of laboratory-developed tests for analyzing patient samples.

SurModics Expands Protein-Free Stabilizer Line with AP Option

SurModics IVD, Inc., a wholly owned subsidiary of SurModics, Inc. (NASDAQ:SRDX) and a market leader for in vitro diagnostic assay components, is introducing StabilZyme® Protein-Free AP Stabilizer at the American Association for Clinical Chemistry meeting currently taking place in C

Ortho-Clinical Diagnostics, Inc. Signs Agreement with Astute Medical, Inc. to Commercialize and Develop Innovative Acute Kidney Injury Tests

Collaboration Enables OCD to Meet Critical Customer Needs Ortho-Clinical Diagnostics, Inc. (OCD) announced it has entered into a strategic partnership with Astute Medical, Inc., under which OCD will become the exclusive commercial partner for the distribution of Astute’s NEPHROCHECK® Test and ASTUTE140® Meter in certain markets in Europe and, pendi...

Studies Presented at World Transplant Congress Support Development of Biomarker Tests Aimed at Improving Transplant Recipient Care

Transplant Genomics Inc. Leads Development of Noninvasive Serial Monitoring Guided by Genomics Studies by the founding scientists of Transplant Genomics Inc. (TGI) to be presented this week at the World Transplant Congress (WTC) are helping lay the groundwork for the company’s development of genomic biomarkers for transplant graft status. The studies...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks